Published in Int J Tuberc Lung Dis on August 01, 2001
Tuberculosis and illicit drug use: review and update. Clin Infect Dis (2009) 1.76
Significance of Tuberculin Testing in HIV Infection: An Indian Perspective. Med J Armed Forces India (2011) 0.75
A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med (1989) 10.98
Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study. JAMA (2001) 5.52
Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring. Clin Infect Dis (2001) 5.43
Detection and treatment of hypertension at the work site. N Engl J Med (1975) 3.43
Knowledge of HIV antibody status and decisions to continue or terminate pregnancy among intravenous drug users. JAMA (1989) 2.41
Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection. N Engl J Med (1992) 2.36
Disease progression and early viral dynamics in human immunodeficiency virus-infected children exposed to zidovudine during prenatal and perinatal periods. J Infect Dis (2000) 2.25
High risk of active tuberculosis in HIV-infected drug users with cutaneous anergy. JAMA (1992) 2.19
Methadone treatment protects against HIV infection: two decades of experience in the Bronx, New York City. Public Health Rep (1998) 1.98
Effects of HIV infection on the serologic manifestations and response to treatment of syphilis in intravenous drug users. Ann Intern Med (1993) 1.92
Regular outpatient medical and drug abuse care and subsequent hospitalization of persons who use illicit drugs. JAMA (2001) 1.81
Increased risk of bacterial pneumonia in HIV-infected intravenous drug users without AIDS. AIDS (1988) 1.75
Neurocognitive performance enhanced by highly active antiretroviral therapy in HIV-infected women. AIDS (2001) 1.68
Prospective study of human immunodeficiency virus infection and pregnancy outcomes in intravenous drug users. JAMA (1989) 1.63
A prospective study of HIV disease progression in female and male drug users. AIDS (1999) 1.54
Lack of association of induration size with HIV infection among drug users reacting to tuberculin. Am J Respir Crit Care Med (1996) 1.47
Heroin use during methadone maintenance treatment: the importance of methadone dose and cocaine use. Am J Public Health (1995) 1.40
Early detection of perinatal human immunodeficiency virus (HIV) type 1 infection using HIV RNA amplification and detection. New York City Perinatal HIV Transmission Collaborative Study. J Infect Dis (1997) 1.36
Needle exchange use among a cohort of injecting drug users. AIDS (1996) 1.26
Association of human immunodeficiency virus (HIV) load early in life with disease progression among HIV-infected infants. New York City Perinatal HIV Transmission Collaborative Study Group. J Infect Dis (1998) 1.22
A prospective study of tuberculosis and human immunodeficiency virus infection: clinical manifestations and factors associated with survival. Clin Infect Dis (1997) 1.11
Human T lymphotropic virus type II (HTLV-II) infection in a cohort of New York intravenous drug users: an old infection? J Infect Dis (1991) 1.06
A prospective study of syphilis and HIV infection among injection drug users receiving methadone in the Bronx, NY. Am J Public Health (1996) 1.02
Correlates of voluntary human immunodeficiency virus antibody testing reported by postpartum women. J Am Med Womens Assoc (1997) 1.01
A prospective study of tuberculosis and HIV disease progression. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 1.01
Shedding of PECAM-1 during HIV infection: a potential role for soluble PECAM-1 in the pathogenesis of NeuroAIDS. J Leukoc Biol (2006) 0.99
Integrating primary care and methadone maintenance treatment: implementation issues. J Addict Dis (1997) 0.97
Vitamin A deficiency and maternal-infant transmissions of HIV in two metropolitan areas in the United States. AIDS (1997) 0.96
Hypertension control among employed persons in New York City: 1973-75. Milbank Mem Fund Q Health Soc (1976) 0.95
Antibody to the human immunodeficiency virus in women seeking abortion in New York City. Ann Intern Med (1987) 0.94
Behavioral risks for HIV infection associated with HIV-testing decisions. AIDS Educ Prev (1996) 0.94
Effectiveness of isoniazid chemoprophylaxis for HIV-infected drug users at high risk for active tuberculosis. AIDS (1999) 0.93
Clinical predictors of Pneumocystis carinii pneumonia, bacterial pneumonia and tuberculosis in HIV-infected patients. AIDS (1998) 0.92
Pilot study of expedited HIV-1 testing of women in labor at an inner-city hospital in New York City. Am J Perinatol (2001) 0.92
Cost-effectiveness of tuberculosis screening and observed preventive therapy for active drug injectors at a syringe-exchange program. J Urban Health (2001) 0.91
In New York City, syringe laws and regulations deter physicians and pharmacists from prescribing and selling syringes to persons who may be injection drug users. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 0.91
Body image in older men with or at-risk for HIV infection. AIDS Care (2007) 0.90
Allelic variants of human beta-chemokine receptor 5 (CCR5) promoter: evolutionary relationships and predictable associations with HIV-1 disease progression. Genes Immun (1999) 0.90
Body image in middle-aged HIV-infected and uninfected women. AIDS Care (2006) 0.89
Increased serum lipids are associated with higher CD4 lymphocyte count in HIV-infected women. HIV Med (2006) 0.88
Prevalence of peripheral neuropathy in injection drug users. Neurology (1999) 0.88
A longitudinal analysis of hospitalization and emergency department use among human immunodeficiency virus-infected women reporting protease inhibitor use. Clin Infect Dis (2001) 0.86
Stress, coping, and attitudes toward HIV treatment in injecting drug users: a qualitative study. AIDS Educ Prev (1995) 0.86
Correlates of health care utilization among HIV-seropositive injection drug users. AIDS Care (2006) 0.83
Organization for long-term management of hypertension: the recruitment, training, and responsibilities of a health team. Bull N Y Acad Med (1976) 0.81
Temporal trends in the progression of human immunodeficiency virus disease in a cohort of drug users. Epidemiology (1998) 0.81
A prospective four-year follow-up of neuropsychological function in HIV seropositive and seronegative methadone-maintained patients. Gen Hosp Psychiatry (1993) 0.81
Development of countermeasures for medical problems encountered in space flight. Adv Space Res (1992) 0.81
The management of HIV disease in pregnancy. Baillieres Clin Obstet Gynaecol (1992) 0.80
Errors in reporting seropositivity for infection with human immunodeficiency virus (HIV) Ann Intern Med (1988) 0.79
CD4+ lymphocyte level and rate of decline as predictors of AIDS in intravenous drug users with HIV infection. AIDS (1993) 0.78
Tampons as a self-administered collection method for the detection and quantification of genital HIV-1. AIDS (2001) 0.78
Correlates of the rate of decline of CD4+ lymphocytes among injection drug users infected with the human immunodeficiency virus. Am J Epidemiol (1993) 0.77
Interactions between HIV-related medications and methadone: an overview. Updated March 2001. Mt Sinai J Med (2001) 0.76
Reliability of anergy skin testing in persons with HIV infection. Am J Respir Crit Care Med (1997) 0.75
Methadone and antiretroviral medications, part I. AIDS Clin Care (1999) 0.75
Self-assessment of tuberculin skin test reactions by drug users with or at risk for human immunodeficiency virus infection. Int J Tuberc Lung Dis (1999) 0.75
Life sciences issues affecting space exploration. Microgravity Sci Technol (1990) 0.75
Overview of HIV and AIDS: biology and epidemiology of the virus. Gastrointest Endosc Clin N Am (1998) 0.75
Association of baseline neuropsychological function and progression of illness over 4 years in HIV-seropositive individuals. Psychosomatics (1994) 0.75
Heterosexual transmission of HIV infection in intravenous and non-intravenous drug-using populations. Arch AIDS Res (1991) 0.75
Effect of prior hepatitis B infection on serum IgE levels in patients with human immunodeficiency virus infection. Ann Allergy Asthma Immunol (1998) 0.75
Neurosyphilis in patients with human immunodeficiency virus infection. N Engl J Med (1995) 0.75
Laboratory markers and the risk of developing HIV-1 disease among injecting drug users. AIDS (1994) 0.75
Ulcerative colitis and hemophilia A. Mt Sinai J Med (1983) 0.75
Directly observed therapy: the medicine works. J Public Health Manag Pract (1995) 0.75
Scientific origins of adolescent sport. Adolescence (1987) 0.75
A seroprevalence survey for human immunodeficiency virus antibody in mentally retarded adults. N Y State J Med (1990) 0.75